Trial Profile
Adherence measured by Medication event monitoring system in TPiple Antihypertensive Combination: single- versus two-pill regimen
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jan 2019
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms AMTRAC
- 02 Jan 2019 Status changed from active, no longer recruiting to completed.
- 19 Mar 2018 Status changed from active, no longer recruiting to recruiting.
- 15 Mar 2018 Status changed from completed to active, no longer recruiting.